Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Somatostatin release" is not the name of a molecule, receptor, or canonical therapeutic target. Instead, it refers to the physiological process by which the hormone somatostatin is secreted from various cells in the body—including neurons and secretory cells in the central and peripheral nervous system, as well as in the gastrointestinal tract and pancreas[1][2][3][4]. Somatostatin itself is a peptide hormone that acts via specific G protein-coupled receptors (somatostatin receptors SSTR1–SSTR5) to inhibit secretion of numerous other hormones and regulate diverse biological functions[5][6][7]. However, "somatostatin release" describes an event or process rather than a discrete molecular entity or druggable target. Therefore, this entry should be flagged as incorrect for structured data extraction about molecular targets.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Somatostatin release.